B Sigurgeirsson

Summary

Country: Iceland

Publications

  1. ncbi request reprint Risk factors for malignant melanoma in an Icelandic population sample
    Vilhjalmur Rafnsson
    Department of Preventive Medicine, University of Iceland, Reykjavik, Iceland
    Prev Med 39:247-52. 2004
  2. doi request reprint A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis
    Bárður Sigurgeirsson
    Dermatology Centre, University of Iceland, Kopavogur, Iceland Electronic address
    J Am Acad Dermatol 69:416-425.e1. 2013
  3. ncbi request reprint Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis
    Bardur Sigurgeirsson
    University of Iceland, Department of Dermatology, Smaratorg 1201, Kopavogur, Reykjavik, Iceland
    Expert Opin Investig Drugs 21:1549-62. 2012
  4. ncbi request reprint [UV-index in Iceland during the summer of 2010]
    Bardur Sigurgeirsson
    Laeknabladid 97:413-6. 2011
  5. ncbi request reprint [Erythemogenic UV rays]
    Bardur Sigurgeirsson
    Laeknabladid 97:417-20. 2011
  6. doi request reprint Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years
    B Sigurgeirsson
    Dermatology Center, Kopavogur, Iceland
    J Eur Acad Dermatol Venereol 24:910-5. 2010
  7. doi request reprint Prognostic factors for cure following treatment of onychomycosis
    B Sigurgeirsson
    Department of Dermatology, University of Iceland, Reykjavik, Iceland
    J Eur Acad Dermatol Venereol 24:679-84. 2010
  8. doi request reprint Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis
    B Sigurgeirsson
    Department of Dermatology, University of Iceland, Reykjavik, Iceland
    J Eur Acad Dermatol Venereol 22:1290-301. 2008
  9. ncbi request reprint Onychomycosis in Icelandic children
    B Sigurgeirsson
    Department of Dermatology, University of Iceland, Iceland
    J Eur Acad Dermatol Venereol 20:796-9. 2006
  10. ncbi request reprint Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison
    Bardur Sigurgeirsson
    Department of Dermatology, University of Iceland, Reykjavik, Iceland
    J Dermatolog Treat 17:38-44. 2006

Collaborators

Detail Information

Publications22

  1. ncbi request reprint Risk factors for malignant melanoma in an Icelandic population sample
    Vilhjalmur Rafnsson
    Department of Preventive Medicine, University of Iceland, Reykjavik, Iceland
    Prev Med 39:247-52. 2004
    ..To describe the constitutional risk factors for malignant melanoma and exposure to sunlight in a population sample in Iceland...
  2. doi request reprint A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis
    Bárður Sigurgeirsson
    Dermatology Centre, University of Iceland, Kopavogur, Iceland Electronic address
    J Am Acad Dermatol 69:416-425.e1. 2013
    ..Onychomycosis is effectively treated with terbinafine and itraconazole. However, frequent repeated dosing is required, and hepatic and cardiac adverse events may occur...
  3. ncbi request reprint Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis
    Bardur Sigurgeirsson
    University of Iceland, Department of Dermatology, Smaratorg 1201, Kopavogur, Reykjavik, Iceland
    Expert Opin Investig Drugs 21:1549-62. 2012
    ..New topical agents that offer efficacy without the potential adverse effects of oral antifungal therapy would benefit patients with this condition and encourage a greater treatment rate...
  4. ncbi request reprint [UV-index in Iceland during the summer of 2010]
    Bardur Sigurgeirsson
    Laeknabladid 97:413-6. 2011
    ..The sensor was located in Skorradalur, Iceland (64,533287N; -21,526338W; altitude 63 m.). The location of the sensor was carefully chosen to ensure that it was never in the shade...
  5. ncbi request reprint [Erythemogenic UV rays]
    Bardur Sigurgeirsson
    Laeknabladid 97:417-20. 2011
    ..The typical Icelander gets red after 4-6 SED and it is obvious that during solar noon it is easy to sunburn in Iceland if you stay outside without sun protection...
  6. doi request reprint Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years
    B Sigurgeirsson
    Dermatology Center, Kopavogur, Iceland
    J Eur Acad Dermatol Venereol 24:910-5. 2010
    ..Standard treatment for onychomycosis often results in less than half of subjects achieving disease-free nails. Onychomycosis is even more challenging to treat as relapses and re-infections are common...
  7. doi request reprint Prognostic factors for cure following treatment of onychomycosis
    B Sigurgeirsson
    Department of Dermatology, University of Iceland, Reykjavik, Iceland
    J Eur Acad Dermatol Venereol 24:679-84. 2010
    ..To examine if host baseline factors and week 24 mycology results are associated with mycological and clinical cure in patients with onychomycosis treated with oral terbinafine...
  8. doi request reprint Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis
    B Sigurgeirsson
    Department of Dermatology, University of Iceland, Reykjavik, Iceland
    J Eur Acad Dermatol Venereol 22:1290-301. 2008
    ..This study was performed to investigate the efficacy and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in children and adolescents with atopic dermatitis (AD)...
  9. ncbi request reprint Onychomycosis in Icelandic children
    B Sigurgeirsson
    Department of Dermatology, University of Iceland, Iceland
    J Eur Acad Dermatol Venereol 20:796-9. 2006
    ..Onychomycosis is a rare disorder in children. Few studies exist on the incidence or prevalence of onychomycosis in children...
  10. ncbi request reprint Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison
    Bardur Sigurgeirsson
    Department of Dermatology, University of Iceland, Reykjavik, Iceland
    J Dermatolog Treat 17:38-44. 2006
    ..Terbinafine is an established drug for the treatment of toenail onychomycosis. Minimizing the total dose of terbinafine and giving it intermittently could improve tolerability as well as compliance, provided efficacy is not compromised...
  11. ncbi request reprint L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis
    B Sigurgeirsson
    Reykjavik City Hospital, Department of Dermatology, Kopavogur, Iceland
    Br J Dermatol 141:5-14. 1999
    ..We conclude that continuous terbinafine is significantly more effective than intermittent itraconazole in the treatment of toenail dermatophyte onychomycosis...
  12. ncbi request reprint Combination therapy for onychomycosis
    J H Olafsson
    Department of Dermatology, Landspitali University Hospital, Tverholt 18, 105 Reykjavik, Iceland
    Br J Dermatol 149:15-8. 2003
    ..Parallel therapy is recommended for patients who are likely to fail therapy (e.g. patients with diabetes), whereas sequential therapy is recommended for patients who show a poor response to initial treatment...
  13. ncbi request reprint Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents
    B Sigurgeirsson
    Department of Dermatology, University of Iceland and Landspitalinn, University Hospital, Reykjavik, Iceland
    Br J Dermatol 147:1241-3. 2002
    ....
  14. ncbi request reprint Risk factors associated with onychomycosis
    B Sigurgeirsson
    Department of Dermatology, University of Iceland and Landspitali, University Hospital, Reykjavik, Iceland
    J Eur Acad Dermatol Venereol 18:48-51. 2004
    ..To examine possible risk factors related to onychomycosis...
  15. ncbi request reprint Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins
    H Sigmundsdottir
    Department of Immunology, National University Hospital, Reykjavik, Iceland
    Scand J Immunol 45:688-97. 1997
    ..This is consistent with the hypothesis that psoriasis may be induced and exacerbated in susceptible individuals by M-protein specific Th1-like cells that cross-react with human epidermal keratin...
  16. ncbi request reprint Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study
    J E Gudjonsson
    Departments of Immunology, Dermatology and Microbiology, Landspitali University Hospital, Hringbraut, Reykjavik, Iceland
    Br J Dermatol 149:530-4. 2003
    ..Guttate psoriasis has a well-known association with streptococcal throat infections but the effects of these infections in patients with chronic psoriasis remains to be evaluated in a prospective study...
  17. pmc Risk factors for cutaneous malignant melanoma among aircrews and a random sample of the population
    V Rafnsson
    Department of Preventive Medicine, University of Iceland, Soltun 1, 105 Reykjavik, Iceland
    Occup Environ Med 60:815-20. 2003
    ....
  18. doi request reprint Two newly identified genetic determinants of pigmentation in Europeans
    Patrick Sulem
    deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
    Nat Genet 40:835-7. 2008
    ....
  19. ncbi request reprint Genetic determinants of hair, eye and skin pigmentation in Europeans
    Patrick Sulem
    deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
    Nat Genet 39:1443-52. 2007
    ..3 is associated with freckles. The fifth region provided refinements to a previously reported association in OCA2, and the sixth encompasses previously described variants in MC1R...
  20. ncbi request reprint Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study
    Hugh Zachariae
    Department of Dermatology, Aarhus University Hospital, Denmark
    Acta Derm Venereol 82:108-13. 2002
    ..The results demonstrate that when studying quality of life in psoriasis, arthritis and arthralgia are important independent factors to be included in the evaluation...
  21. ncbi request reprint Dermatophytes in a swimming pool facility: difference in dermatophyte load in men's and women's dressing rooms
    Ingibjorg Hilmarsdottir
    Acta Derm Venereol 85:267-8. 2005
  22. ncbi request reprint Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study
    Jean Claude Roujeau
    Service de Dermatologie, Hopital Henri Mondor, Creteil, France
    Dermatology 209:301-7. 2004
    ..To assess the role of foot dermatomycosis (tinea pedis and onychomycosis) and other candidate risk factors in the development of acute bacterial cellulitis of the leg...